Log on / register
Feedback | Support | My details
Printer friendly version
View previous editions of the BMC Update

Advertisement

 
Wednesday 01 July 2009
 

The 2008 edition of Thomson Reuters' Journal Citation Report has been released, with strong performance and improvements reported across BioMed Central's journal portfolio.

The BMC series of journals continues to flourish with both BMC Medicine (IF 3.28) and BMC Systems Biology (IF 3.71) receiving impressive first Impact Factors. BioMed Central's cancer journals were another highlight, with Breast Cancer Research (IF 5.05) and Molecular Cancer (IF 5.36) both seeing major increases.

In all, 12 titles received their first Impact Factor this year, bringing the total number of BioMed Central journals with official Impact Factors to 58. For further details, including a list of all the new Impact Factors for BioMed Central's journals, see BioMed Central's blog.


BioMed Central on Twitter
With Twitter increasingly prominent as a tool for scientific communication, we have added a 'Post to Twitter' link to all our articles. You can also stay up to date via our new Twitter feed, which includes blog posts, hot article notifications and other short updates from BioMed Central.


New from Genome Medicine - Copy number variation: larger clues to cancer?
'Copy number variations and cancer', a Review article published in Genome Medicine,  describes the emerging importance of the role of genetic structural variation and diversity in cancer.

Copy number variations (CNV) are large, structurally variant regions of DNA that contribute substantially to genetic diversity. Until recently, the majority of genomic studies in cancer have focused on the single-nucleotide polymorphisms associated with different forms of the disease. Technological progress in the form of high-resolution SNP arrays, however, has allowed the identification of increasing numbers of CNVs and the association of these components of genetic variation with different forms of cancer has become apparent.

Stem Cell Research & Therapy: a call for papers
Stem Cell Research & Therapy
A new BioMed Central journal that aims to be the major forum for translational research into stem cell therapies is ready to receive submissions.
 
New supplements
 
Infectious Agents and Cancer   Infectious Agents and Cancer has published the proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research. Bethesda, MD, USA. 6-7 October 2008.
 
BMC Neurology   BMC Neurology has published the proceedings of the 2009 Drug Discovery for Neurodegeneration Conference. Washington, DC, USA. 2-3 February 2009.
 
BMC Bioinformatics   BMC Bioinformatics has published the abstracts from the UT-ORNL-KBRIN Bioinformatics Summit 2009. Pikeville, TN, USA. 20-22 March 2009.

Patients' anatomical knowledge limited   Patients' anatomical knowledge limited
BMC Family Practice 2009, 10:43
Knowledge of the location of body organs among patients and the general public is limited and has remained unchanged during the last 30 years, highlighting the need for physicians to avoid making assumptions about patient understanding during consultations.
 
Trial shows promise for arthritis drug   Trial shows promise for arthritis drug
Arthritis Research & Therapy 2009, 11:R95
A small clinical trial has shown masitinib to be generally well tolerated and effective in the treatment of rheumatoid arthritis, indicating the need for further placebo-controlled studies.

The 1001 Genomes Project for Arabidopsis thaliana
Detlef Weigel and Richard Mott
Genome Biology 2009, 10:107 (27 May 2009)

 
 


BioMed Central
will be exhibiting at:

ICAD
Vienna, Austria
12 - 15 July
Booth #119

ESOC
Prague, Czech Republic
12 - 16 July
Booth #3

ICPEAC
Kalamazoo, Michigan
22 - 28 July
Booth #7

BioMed Central will be exhibiting at many upcoming conferences.



Role of zebrafish survivin genes in neurodevelopment.

BioMed Central Ltd, 236 Gray's Inn Road,
London, WC1X 8HL, United Kingdom. Privacy Policy

Advertisement



© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.